Results 101 to 110 of about 117,266 (149)
A tumour-associated antigen from the pleural effusion of patients with squamous-cell carcinoma of lung [PDF]
A.P. Wolf
openalex +1 more source
The association between BMD reduction during NAC and the worse prognosis remains unknown, although NAC followed by esophagectomy is a standard treatment for advanced ESCC. This study appeared that BMD massive reduction was an independent prognostic factor on OS (HR, 3.30; 95% confidence interval [CI], 1.69–6.55) and RFS (HR, 2.08; 95% CI, 1.19–3.63 ...
Kazuhide Sato+11 more
wiley +1 more source
Some Pathological Data on 2000 Adenocarcinomas and Squamous Cell Carcinomas of the Lung
Wilson IB Onuigbo
openalex +1 more source
This multicenter study investigated 14 152 minimally invasive esophagectomies (MIEs) using data from the Japanese National Clinical Database and showed a significantly lower operative mortality rate in high‐volume centers than in low‐volume centers. However, no differences in morbidity rates were found between facility sizes.
Taro Oshikiri+4 more
wiley +1 more source
This study aimed to investigate survival outcomes, the efficacy of lymph node (LN) dissection, and recurrence patterns in 69 patients who underwent R0 salvage surgery for esophageal squamous cell carcinoma. Of note, abdominal LN metastases had a negative impact on survival in our series.
Kotaro Sugawara+9 more
wiley +1 more source
This multi‐institutional, randomized, phase II trial aimed to investigate the long‐term survival outcomes of two versus three courses of DCF for locally advanced esophageal squamous cell carcinoma (ESCC). The 5‐year overall survival and progression‐free survival rates for the three and two course groups were 70.7% vs. 63.8% (hazard ratio (HR) = 0.91, p
Takahito Sugase+19 more
wiley +1 more source
A Case of Squamous-Cell Carcinoma developing in the Chronic Sinuses of Osteomyelitis
K. Hirata, R. Hoki
openalex +2 more sources
Leukocyte migration inhibition assay of tumor immunity in patients with cervical squamous cell carcinoma [PDF]
Ernesto S. Rivera+5 more
openalex +1 more source
This study introduces an immunomodulatory DNA tetrahedral framework nucleic acid‐based nanovaccine tFNA‐CpG. The functionalized nanovaccine shows stable and well‐defined morphological characteristics and can be efficiently taken up by APCs. When combined with the immune checkpoint inhibitor anti‐PD‐1, it notably ameliorated the immunosuppressive ...
Xueting Yang+12 more
wiley +1 more source